Leukemia & Lymphoma Society
North America, New York, United States, White Plains
Description
Leukemia & Lymphoma Society, a voluntary health organization, funds research, finds cures, and offers treatments for blood cancer patients.
Investor Profile
Leukemia & Lymphoma Society has backed more than 18 startups, with 0 new investments in the last 12 months alone. The firm has led 4 rounds, about 22% of its total and boasts 10 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Post Ipo Equity, Series B, Series C rounds (top funding stages).
- Majority of deals are located in United States, Finland, France.
- Strong thematic focus on Biotechnology, Health Care, Medical.
Stage Focus
- Post Ipo Equity (28%)
- Series B (22%)
- Series C (17%)
- Series Unknown (11%)
- Corporate Round (6%)
- Grant (6%)
- Series D (6%)
- Seed (6%)
Country Focus
- United States (61%)
- Finland (11%)
- France (6%)
- Poland (6%)
- Sweden (6%)
- Germany (6%)
- Switzerland (6%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Therapeutics
- Pharmaceutical
- Oncology
- Biopharma
- Life Science
- Clinical Trials
- Hospital
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
